The deadline for abstract submission is October 1, 2008. All submissions should not exceed 450 words.

The Scientific Committee requests that authors submit their abstracts electronically via the Conference website. To submit electronically please click on the button at the bottom of the page and follow the step-by-step directions, which will enable you to upload the file containing your abstract from the computer system that you are using to access this website. To ensure your abstract retains any special characters or formatting, the abstract must be in Microsoft Word format.

Format
The body of the uploaded abstract submission should not exceed 450 words; this limit excludes the title, authors and affiliations.

Clearly define all concepts and abbreviations at first use. If English is not your primary language, attempt to have your abstract reviewed by a native English speaker. To be acceptable, abstracts shall contain a concise statement of the research. It is recommended that the author follow the structured format below:

Title (not included in 450 word limit)
Use a short and concise title that indicates the content of the abstract. Capitalize the first letter of each word except prepositions, articles, and species names. Species names should be spelled out at first use. Italicize scientific names of organisms (example: Staphylococcus aureus). For therapeutic agents, only generic names may be used (no trade names are permitted in abstract titles).

Authors/Affiliations (not included in 450 word limit)
Authors' names should be entered using initial(s) for the first and middle names followed by the full last name, with presenting author underlined (e.g. AN Author1, AN Author2 and AN Author3).

All author affiliations should be entered as follows:
1 University of London, London, UK; 2 University of Frankfurt, Frankfurt, Germany; and 3 University of Paris, Paris, France.

Background
State the problem under investigation or a hypothesis. For therapeutic agents, only generic names may be used (no trade names are permitted). No figures or tables are allowed.

Methods
Explain the experimental methods used. For therapeutic agents, only generic names may be used (no trade names are permitted). No figures or tables are allowed.

Results
List the essential results obtained in summary form, with enough quantitative data to permit evaluation by reviewers. For therapeutic agents, only generic names may be used (no trade names are permitted). No figures or tables are allowed.

Conclusion
Summarize the findings. It is unacceptable to use statements such as "the results will be discussed". For therapeutic agents, only generic names may be used (no trade names are permitted). Simple figures or tables are allowed.

In addition to the uploaded abstract, the following additional information will be collected on the abstract submission form:

Contact Information
The presenting author must enter a complete address to ensure that correspondence arrives promptly and easily.

Preferred Form of Presentation
Poster, Oral, Either

Abstract Category
For purposes of review and programming, abstracts are divided into topical categories. Selection of the most appropriate category is important as it determines who reviews your abstract. The Organizing Committee reserves the right to reassign your abstract to a more appropriate category. 

• HIV Therapy in Developing Countries
• HIV/Hepatitis and Other Co-infections
• HIV Prevention and Eradication
• Therapeutic and Immunological Approaches
• Pathogenesis, Animal Models and Targeted Design
• Pharmacology and Drug Metabolism
• Resistance to Antiviral Drugs
  

Abstract Title (should be the same as in the uploaded abstract)
Use a short and concise title that indicates the content of the abstract. Capitalize the first letter of each word except prepositions, articles, and species names. Species names should be spelled out at first use. Italicize scientific names of organisms (example: Staphylococcus aureus). For therapeutic agents, only generic names may be used (no trade names are permitted in abstract titles).

Sample Abstract
To view a sample abstract, click here.

The sample form is an Adobe Acrobat document. If your computer cannot read the sample, please click here to download Adobe's free Acrobat Reader.

Notifications of acceptance and format of presentation (oral or poster presentation) will be announced on October 15, 2008. It is the responsibility of the corresponding/presenting author to inform all co-authors of the disposition status. If you have not received notification by October 17, 2008, please call +1 (781) 648-1933.

If an abstract is accepted, one author is required to register for the conference and present the paper as scheduled.  Guidelines for preparing your poster presentations will be sent if your abstract is accepted. It is suggested that all accepted posters be set up prior to
December 10, 2008.

Accepted abstracts will be standardized in font and presentation. Abstracts will NOT be edited in any way. Thus, any error that appears in the submitted abstract will appear in the printed abstract.

Subject to availability, copies of the Abstract Book will be available for sale after the Conference. Please contact the Conference Secretariat.